In-House Biomarker Testing Shortens Time to Treatment Decisi

This retrospective analysis compared molecular testing outcomes among newly diagnosed cases of metastatic non–small cell lung cancer (mNSCLC) from 2 periods: March 2017 to May 2019 and July 2019 to March 2021.

Related Keywords

Sunnybrook , Alberta , Canada , Toronto , Ontario , , Sunnybrook Health Sciences Centre , From March , Mnsclc , Metastatic Non Small Cell Lung Cancer , In House Testing , Time To Treatment Decision ,